Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951).
about
Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951).
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951).
@ast
Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951).
@en
Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951).
@nl
type
label
Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951).
@ast
Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951).
@en
Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951).
@nl
prefLabel
Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951).
@ast
Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951).
@en
Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951).
@nl
P2860
P356
P1433
P1476
Structure, development, preclinical and clinical efficacy of tivozanib (KRN-951, AV-951).
@en
P2093
Brigitte C M Haberkorn
Ferry A L M Eskens
P2860
P356
10.2217/FON.12.167
P407
P577
2013-01-01T00:00:00Z